In our model, BD indeed increased IL-6 levels in the serum, which was reduced by both treatments; the same reduction was observed in the long-term analysis of IL-6 explant levels, indicating that after transplant, IL-6 levels could be controlled by both treatments. This evidence concerns the gene IL6 and Behcet disease.